ICS 2018 Scientific Open Discussion Session S7

Open Discussion ePosters

Scientific Open Discussion Session S7

Speakers
	Wednesday 29th August 2018
	12:00 - 13:00
	Exhibition Hall
S Sender Herschorn ICS Chair M Marco H Blanker ICS Chair A Ashani Couchman ICS Chair J Joan Ostaszkiewicz ICS Chair A Adelia Lucio ICS Chair J Julien Renard ICS Chair M Marcio Augusto Averbeck ICS Chair B Becky Clarkson ICS Chair N Nikolaus Veit-Rubin ICS Chair M Melissa Clare Davies ICS Chair C Cristian Persu ICS Chair T Tufan Tarcan ICS Chair

Abstracts	ePoster Station	Track	Topics	Chair
67 - 76	1	Urology	Male Lower Urinary Tract Symptoms	Sender Herchorn
77 - 86	2	Urology	Male Lower Urinary Tract Symptoms	Cristian Persu
87 - 97	3	Urology	Male Lower Urinary Tract Symptoms	Marco Blanker
98 - 106	4	Urology	Male Lower Urinary Tract Symptoms	Ashani Couchman
107 - 117	5	Urology	Male Lower Urinary Tract Symptoms / Nocturia	Joan Ostaszkiewicz
118 - 125	6	Urology	Nocturia / Overactive Bladder	Adelia Lucio
126 - 136	7	Urology	Overactive Bladder	Julien Renard
137 - 147	8	Urology	Overactive Bladder	Marcio Averbeck
148 - 157	9	Urology	Overactive Bladder	Becky Clarkson
158 - 167	10	Urology	Paediatrics / Prostate Clinical, Surgical / Urethra Male , Female	Tufan Tarcan
168 - 175	11	Urology	Urodynamics	Nikolaus Veit-Rubin
176 - 185	12	Urology	Urethra Male , Female / Overactive Bladder / Urodynamics	Melissa Davies

Session Schedule

12:05

#67 Long-term prevalence of post-prostatectomy urinary incontinence according to different definitions and its association with perioperative parameters

Presenter: Marcio Augusto Averbeck

Averbeck M A¹, da Silva L F B², Rhoden E L³
1. Moinhos de Vento Hospital & Federal University of Health Sciences of Porto Alegre (UFCSPA), Brazil, 2. Residency in Urology, UFCSPA, 3. Moinhos de Vento Hospital, Santa Casa Hospital Complex & UFCSPA
Detrusor Overactivity, Male, Pathophysiology, Stress Urinary Incontinence
ePoster Station 1

12:10

#68 Expression of nerve growth factor, vascular endotelial growth factor and connective tissue growth factor in the detrusor of patients with bladder outlet obstruction due to benign prostatic hyperplasia

Presenter: Thiago Souto Hemerly

Bellucci C H S¹, Hemerly T S¹, Bessa Jr J¹, Barbosa J A B A¹, Guimarães V R¹, Viana N I¹, Camargo G M¹, Reis S T D¹, Bruschini H¹, Srougi M¹, Leite K R¹, Gomes C M¹
1. University of Sao Paulo
Basic Science, Benign Prostatic Hyperplasia (BPH), Bladder Outlet Obstruction , Pathophysiology
ePoster Station 1

12:15

#69 What do men with uncomplicated LUTS expect from secondary care?

Presenter: Pim Brandenbarg

Brandenbarg P¹, Rooijers P¹, Steffens M², Van Balken M³, Blanker M H¹
1. University Medical Center Groningen, Department of General Practice, 2. Isala Zwolle, Department of Urology, 3. Rijnstate Arnhem, Department of Urology
Male, Prospective Study, Benign Prostatic Hyperplasia (BPH), Questionnaire
ePoster Station 1

12:20

#70 Evidence against consensus: what should be the components of a new online self-management program for men with uncomplicated LUTS?

Presenter: Pim Brandenbarg

Brandenbarg P¹, Slijkhuis B¹, Jellema P¹, Steffens M², Van Balken M³, Blanker M H¹
1. University Medical Center Groningen, Department of General Practice, 2. Isala Zwolle, Department of Urology, 3. Rijnstate Arnhem, Derpartment of Urology
Male, Questionnaire, Conservative Treatment, Voiding Dysfunction , Benign Prostatic Hyperplasia (BPH)
ePoster Station 1

12:25

#71 Cost-effectiveness of greenlight photoselective vaporization of the prostate compared to transurethral resection of the prostate for benign prostatic hyperplasia

Presenter: Dean Elterman

Elterman D¹, Masucci L², Erman A², Shepherd S¹, Krahn M²
1. University Health Network, 2. The Toronto Health Economics and Technology Assessment Collaborative (THETA)
Benign Prostatic Hyperplasia (BPH), Male, Overactive Bladder
ePoster Station 1

12:30

#72 Efficacy and safety of proact for the treatment of male post-surgical stress urinary incontinence: a systematic review of literature

Presenter: Valerio Iacovelli

Orecchia L¹, Iacovelli V¹, Farullo G², Turbanti A², Petta F¹, Vespasiani G¹, Finazzi Agrò E¹
1. University of Rome Tor Vergata, Department of Experimental Medicine and Surgery, Urology Unit, Rome, Italy, 2. Urology Residency Program, University of Rome Tor Vergata, Rome, Italy
Male, Stress Urinary Incontinence, Surgery
ePoster Station 1

12:35

#73 Long-term efficacy of adjustable device for male stress urinary incontinence

Presenter: Raquel González-López

Garde-García H¹, González-López R², González-Enguita C²
1. H.U. Fundación Jiménez Díaz, Madrid (Spain), 2. H.U. Fundación Jiménez Díaz and H.U. Infanta Elena, Madrid (Spain)
Incontinence, Male, New Devices, Surgery
ePoster Station 1

12:40

#74 Comparison of Postoperative Continence Status of the Patients who Underwent Robot-Assisted Laparoscopic Radical Prostatectomy and Retropubic Radical Prostatectomy

Presenter: Fuat Kizilay

Kizilay F¹, Ismaylov F¹, Simsir A¹, Özyurt C¹
1. Ege University School of Medicine, Department of Urology
Incontinence, Male, Stress Urinary Incontinence, Surgery
ePoster Station 1

12:45

#75 Male sling versus artificial urinary sphincter: which device should we choose?

Presenter: Maria Ercilia Zubieta

Gonzalez M I¹, Esquenazi G¹, Jaunarena J H¹, Zubieta M E¹, Favre G A¹, Tejerizo J C¹
1. Hospital Italiano de Buenos Aires
Incontinence, Male, Pad Test, Retrospective Study
ePoster Station 1

12:50

#76 The association of risk factors with lower urinary tract symptoms: The Community Health Survey.

Presenter: Kyu Shik Kim

Kim K S¹, Kim Y T¹, Lee J A², Choi B Y², Moon H S¹
1. Department of Urology, Hanyang university hospital, Seoul, Korea, 2. Department of Preventive Medicine, Hanyang University College of Medicine, Seoul, Korea
Benign Prostatic Hyperplasia (BPH), Male, Voiding Dysfunction
ePoster Station 1

12:05

#77 The Role of Educational Level and Cognitive Status of Patients on Outcomes and Revision Rates of Artificial Urinary Sphincter in Men with Post-Prostatectomy Incontinence: The First Multi-Institutional Study in Turkish Men

Presenter: Ahmet Keles

Keles A¹, Onur R², Dincer M³, Koca O⁴, Coskun B⁵, Karakeci A⁶, Garayev A⁷
1. Istanbul Esenyurt State Hospital,Department of Urology,Istanbul,Turkey, 2. Marmara University School of Medicine,Department of Urology,Istanbul,Turkey, 3. Bagcilar Education and Research Hospital,Department of Urology,Istanbul,Turkey, 4. Haydarpasa Numune Education and Research Hospital,Department of Urology,Istanbul,Turkey, 5. Uludag University School of Medicine,Department of Urology,Bursa,Turkey, 6. Firat University School of Medicine,Department of Urology,Elazig,Turkey, 7. Istanbul Bilim University,Florance Nightingale Hospital,Department of Urology,Istanbul,Turkey
Male, Incontinence, New Instrumentation, Stress Urinary Incontinence, Quality of Life (QoL)
ePoster Station 2

12:10

#78 Correlation of transient receptor potential cation channel subfamily V proteins in patients with different clinical severity of ketamine cystitis

Presenter: Jia-Fong Jhang

Yang H¹, Jhang J², Wang H², Huang H¹, Zhai W¹, Kuo H²
1. Department of Research, Buddhist Tzu Chi General Hospital, Hualien, Taiwan, 2. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Painful Bladder Syndrome/Interstitial Cystitis (IC), Pathophysiology, Voiding Diary
ePoster Station 2

12:15

#79 The baseline videourodynamic findings and long-term therapeutic outcome in male IC/BPS patients

Presenter: Jia-Fong Jhang

Kuo Y¹, Jhang J², Yeh H³, Kuo H²
1. Department of Urology, Yangming Branch of Taipei City Hospital, Taipei, Taiwan, 2. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan, 3. Department of Nursing, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
Male, Painful Bladder Syndrome/Interstitial Cystitis (IC), Voiding Dysfunction
ePoster Station 2

12:20

#80 Morbidity rate and medical utilization of chronic prostatitis-population based study

Presenter: Ming-Huei Lee

Lee M¹, Chang K², Lin H³, Wu H⁴
1. Department of Urology, Taichung Hospital, Ministry of Health and welfare, Taichung, Taiwan. Department of Management Information Systems, Central Taiwan University of Science and Technology, Taichung, Taiwan, 2. Department of Obstetrics and Gynecology, Feng Yuan Hospital, Ministry of Health and Welfare, Taichung, Taiwan. Central Taiwan University of Science and Technology, Taichung, Taiwan, 3. Department of anaesthesiology, Feng Yuan Hospital, Ministry of Health and welfare, Taichung, Taiwan, 4. Department of Urology, Taichung Hospital, Ministry of Health and welfare, Taichung, Taiwan
Pain, Pelvic/Perineal, Benign Prostatic Hyperplasia (BPH), Retrospective Study
ePoster Station 2

12:25

#81 Risk factors of deterioration of lower urinary tract symptoms in elderly men - Community-based, Prospective Longitudinal Cohort Study

Presenter: Seong Ho Lee

Lee S H¹, Choo M S¹, Cho S T², Oh C Y³, Kim J K¹
1. Hallym University Dongtan Sacred Heart Hospital, 2. Hallym University Kangnam Sacred Heart Hospital, 3. Hallym University Sacred Heart Hospital
Benign Prostatic Hyperplasia (BPH), Male, Pathophysiology
ePoster Station 2

12:30

#82 The effect of mirabegron on bladder blood flow in a rat model of bladder outlet obstruction

Presenter: Tsuyoshi Majima

Majima T¹, Funahashi Y¹, Takai S¹, Matsukawa Y¹, Yamamoto T¹, Gotoh M¹
1. Nagoya University Graduate School of Medicine
Animal Study, Bladder Outlet Obstruction , Pharmacology
ePoster Station 2

12:35

#83 Diuretic adaptation as a predictor of the efficacy of add-on therapy for overactive bladder symptoms in men treated for low urinary tract symptoms

Presenter: Kanako Matsuoka

Matsuoka K¹, Aikawa K¹, Akaihata H¹, Hoshi S¹, Hata J¹, Sato Y¹, Kataoka M¹, Ogawa S¹, Haga N¹, Ishibashi K¹, Kojima Y¹
1. Department of Urology, Fukushima Medical University School of Medicine
Benign Prostatic Hyperplasia (BPH), Overactive Bladder, Retrospective Study
ePoster Station 2

12:40

#84 Proposal of a new way to evaluate the external sphincter function prior male sling surgey

Presenter: Daniel Moser

Moser D¹, D`Ancona C¹, Voris B R I¹, Martins D¹, Jane K², Herny G²
1. Unicamp, 2. Ark-La-Tex Urology
Incontinence, Urodynamics Techniques, Prospective Study, Pelvic Floor
ePoster Station 2

12:45

#85 ICIQ-SF score versus pad use for continence assessment following radical prostatectomy

Presenter: Sean F Mungovan

Mungovan S F¹, Graham P L², Pascual J I³, Robles J³, Patel M I⁴, Tienza A³
1. The Clinical Research Institute and Westmead Private Physiotherapy Services, Westmead NSW, Australia, 2. Department of Statistics, Macquarie University, Australia, 3. Department of Urology, Clinica Universidad de Navarra, Pamplona, Spain, 4. Discipline of Surgery, Sydney Medical School, The University of Sydney, Australia and Department of Urology, Westmead Hospital, Sydney, Australia
Outcomes Research Methods, Incontinence, Male
ePoster Station 2

12:50

#86 Sensory Protein Expression and Urethral Mucosal Dysfunction in the Pathogenesis of Male Bladder Neck Dysfunction and Benign Prostatic Obstruction

Presenter: Yu-Khun Lee

Jiang Y¹, Lee Y¹, Lee C¹, Kuo H¹
1. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Male, Pathophysiology, Voiding Dysfunction
ePoster Station 2

12:05

#87 Multicentre experience with the refillable artificial urinary sphincter ZSI 375 PF

Presenter: Bárbara Padilla-Fernández

Padilla-Fernández B¹, González-López R², Resel-Folkersma L³, Garde-García H², Hernández-Hernández D¹, Madurga-Patuel B⁴, Lorenzo-Gómez M F⁵, Moreno-Sierra J³, González-Enguita C², Castro-Díaz D M¹
1. Department of Urology, Hospital Universitario de Canarias, Tenerife, Spain, 2. Department of Urology, Fundación Jiménez Díaz University Hospital, Madrid, Spain, 3. Department of Urology, Hospital Clínico San Carlos, Madrid, Spain, 4. Department of Urology, Hospital Puerta del Mar, Cádiz, Spain, 5. Department of Urology, Complejo Hospitalario Universitario de Salamanca, Salamanca, Spain
Incontinence, Male, Surgery, New Devices
ePoster Station 3

12:10

#88 Results of the surgical correction of male urinary incontinence due to prostate cancer treatment with Remeex®

Presenter: Bárbara Padilla-Fernández

Padilla-Fernández B¹, Sanz-Ruiz A², Sousa-Escandón A³, Perán-Teruel M⁴, Hernández-Hernández D¹, García-Cenador M B⁵, Castro-Díaz D M¹, Lorenzo-Gómez M F⁶
1. Department of Urology, Hospital Universitario de Canarias, Tenerife, Spain, 2. Department of Urology, Complejo Hospitalario Universitario de León, León, Spain, 3. Department of Urology, Hospital de Monforte de Lemos, Lugo, Spain, 4. Department of Urology, Hospital Arnau de Vilanova, Valencia, Spain, 5. Department of Surgery, University of Salamanca, Salamanca, Spain, 6. Department of Urology, Complejo Hospitalario Universitario de Salamanca, Salamanca, Spain
Incontinence, Male, Surgery, New Devices
ePoster Station 3

12:15

#89 Single-incision technique to implant an artificial urinary sphincter in male patients

Presenter: Tobias S Pottek

Pottek T S¹, Neugart F²
1. Vivantes Klinikum Am Urban, 2. Klinikum Baden-Baden
Incontinence, Male, New Devices, Surgery
ePoster Station 3

12:20

#90 Technique to implant the new artificial urinary sphincter VICTO+

Presenter: Tobias S Pottek

Pottek T S¹, Huebner W A²
1. Vivantes Klinikum Am Urban, 2. Klinikum Korneuburg
Incontinence, Male, New Devices, Stress Urinary Incontinence, Surgery
ePoster Station 3

12:25

#91 Evaluation of quality of life with Desmopressin add on alpha blockers in treatment of lower urinary tract symptoms of Benign Prostatic hyperplasia

Presenter: Mohamed ElBendary

Rasheed M¹, ElBendary M¹, Bakary M¹, ElNagar I¹
1. Tanta Faculty of Medicine Egypt
Benign Prostatic Hyperplasia (BPH), Nocturia, Quality of Life (QoL)
ePoster Station 3

12:30

#92 Voiding pattern monitoring, is it important in evaluation of successful distal hypospadias repair surgery?

Presenter: Mohamed Rasheed

Rasheed M¹, ElBendary M¹, Damhougy M²
1. Tanta Faculty of Medicine Egypt, 2. Insurance Hospital Tanta Egypt
Pediatrics, Questionnaire, Outcomes Research Methods
ePoster Station 3

12:35

#93 The use of Nanotechnology structured water magnalife improves the outcome of conservative treatment for lower urinary tract symptoms.

Presenter: Ismael Hama-Amin Akha Weas

M. Sami A K¹, Akha Weas I H¹, A. Alrahman M S²
1. Dept. of urology/college of Medicine/University of Sulaymaniyah, 2. Dept. of Conservative/college of Dentistry/University of Sulaymaniyah
Benign Prostatic Hyperplasia (BPH), Conservative Treatment, Clinical Trial
ePoster Station 3

12:40

#94 Novel imaging techniques reveal disturbed function of prostate ducts by alpha1-adrenergic receptor blockers but not by PDE5-inhibitors in the treatment of BPH

Presenter: Mathias Seidensticker

Seidensticker M¹, Exintaris B², Kügler R¹, Mietens A¹, Tasch S¹, Wagenlehner F M³, Risbridger G P⁴, Middendorff R¹
1. Institute of Anatomy and Cell Biology, Justus-Liebig University Giessen, Germany, 2. Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Melbourne, Australia, 3. Department of Urology, Pediatric Urology and Andrology, Justus-Liebig University Giessen, Germany, 4. Prostate and Breast Cancer Research Group, Department of Anatomy & Developmental Biology, Monash University, Melbourne, Australia
Benign Prostatic Hyperplasia (BPH), Imaging, Male
ePoster Station 3

12:45

#95 Efficacy and Safety of Doxazosin versus Tamsulosin for the Treatment of Male LUTS – A Network Meta-Analysis

Presenter: Matthias Oelke

Oelke M¹, Chopra I², Patel D², Tang W Y³, Hassan T³
1. Dept. of Urology, St. Antonius Hospital, Gronau, Germany, 2. Pharmerit, MD, USA, 3. Pfizer Inc, NY, USA
Benign Prostatic Hyperplasia (BPH), Male, Voiding Dysfunction
ePoster Station 3

12:50

#96 With what degree of improvement in Patient Reported Outcome Measures is resolution of OAB symptoms associated? Data from a pooled analysis of OAB treatment with fesoterodine.

Presenter: Matthias Oelke

Wagg A¹, LaBossiere J R², Herschorn S², Fernet M³, Carlsson M³, Oelke M⁴
1. University of Alberta, Edmonton, Alberta, Canada, 2. University of Toronto, Toronto, Ont, Canada, 3. Pfizer Canada, Montreal, QC, Canada, 4. St. Antonius-Hospital Akademisches Lehrkrankenhaus der WWU Münster, Gronau, Germany
Overactive Bladder, Quality of Life (QoL), Female, Male
ePoster Station 3

12:55

#97 Isosamidin, an extract of Peucedanum japonicum, may have pharmacological potency in the treatment of male lower urinary tract symptoms

Presenter: Takahisa Suzuki

Suzuki T¹, Otsuka A¹, Ito Y², Yamada S³, Miyake H¹, Ozono S¹
1. Department of Urology, Hamamatsu University School of Medicine, 2. Department of Pharmacokinetics and Pharmacodynamics, School of Pharmaceutical Sciences, University of Shizuoka, 3. Center for Pharma-Food Research, Graduate School of Pharmaceutical Sciences, University of Shizuoka
Basic Science, Physiology, Pharmacology
ePoster Station 3

12:05

#98 Novel tube positioning technique for AMS 800™ artificial urinary sphincter placement

Presenter: Emanuele Rubilotta

Balzarro M¹, Rubilotta E¹, Sebben M¹, Bassi S¹, Cerruto M A¹, Porcaro A B¹, Pianon R¹, Artibani W¹
1. Dept. of Urology, AOUI Verona, Italy
Biomechanics, Incontinence, Male, Surgery, Stress Urinary Incontinence
ePoster Station 4

12:10

#99 Comparison between uroflowmetry and international prostate symptoms score in males with lower urinary tract symptoms

Presenter: Emanuele Rubilotta

Rubilotta E¹, Balzarro M¹, Righetti R², Trabacchin N¹, Bassi S¹, Processali T¹, Pirozzi M¹, Curti P², Cerruto M A¹, D'Amico A¹, Artibani W¹
1. Dept. of Urology, AOUI Verona, Italy, 2. Dept. of Urology, Ospedale Mater Salutis, ULSS 9 Scaligera, Legnago, Italy
Questionnaire, Male, Voiding Dysfunction , Prospective Study
ePoster Station 4

12:15

#100 Nocturnal polyuria in males with LUTS: prevalence and role of the International Prostate Symptom Score and uroflowmetry in the outpatient evaluation. An observational, prospective double-centere study.

Presenter: Emanuele Rubilotta

Bassi S¹, Rubilotta E¹, Balzarro M¹, Righetti R², Trabacchin N¹, Processali T¹, Pirozzi M¹, Curti P², Cerruto M A¹, D'Amico A¹, Artibani W¹
1. Dept. of Urology, AOUI Verona, Italy, 2. Dept. of Urology, Ospedale Mater Salutis, ULSS 9 Scaligera, Legnago, Italy
Voiding Diary, Nocturia, Questionnaire, Quality of Life (QoL), Prospective Study
ePoster Station 4

12:20

#101 OnabotulinumtoxinA detrusor injection improves female sexual function in women with idiopathic wet overactive bladder syndrome

Presenter: Emanuele Rubilotta

Balzarro M¹, Rubilotta E¹, Braga A², Bassi S¹, Processali T¹, Artibani W¹, Serati M³
1. Dept. of Urology Azienda Ospedaliera Universitaria Integrata of Verona. Piazzale Aristide Stefani 1, Verona, 37126, Italy., 2. Dept. of Dept. of Obstetrics and Gynecology, EOC - Beata Vergine Hospital, via Turconi 23, Mendrisio, 6850, Switzerland, 3. Dept. of Obstetrics and Gynecology, University of Insubria, via Ravasi 2, Varese, 21100, Italy.
Urgency Urinary Incontinence, Surgery, Sexual Dysfunction , Detrusor Overactivity, Overactive Bladder
ePoster Station 4

12:25

#102 A comparison of Schaefer, International Continence Society and bladder contractility index nomograms in the diagnosis of obstruction and detrusor underactivity in men with lower urinary tract symptoms

Presenter: Emanuele Rubilotta

Rubilotta E¹, Balzarro M¹, Trabacchin N¹, Bassi S¹, D'Amico A¹, Cerruto M A¹, Artibani W¹
1. Dept. of Urology, AOUI Verona, Italy
Detrusor Hypocontractility, Male, Bladder Outlet Obstruction , Underactive Bladder, Urodynamics Techniques
ePoster Station 4

12:30

#103 A new Artificial Urinary Sphincter (VICTO) with conditional occlusion for stress incontinence: preliminary clinical results.

Presenter: Peter Weibl

Weibl P¹, Ameli G¹, Hoelzel R¹, Rutkowski M¹, Huebner W A¹
1. Department of Urology, Teaching Hospital, Landesklinikum Korneuburg, Korneuburg, Austria
Male, Incontinence, Stress Urinary Incontinence, Surgery, New Instrumentation
ePoster Station 4

12:35

#104 Using stress-relief cuff to improve urine leakage after artificial urinary sphincter implantation

Presenter: Peter Weibl

Weibl P¹, Ameli G¹, Rutkowski M¹, Huebner W A¹
1. Department of Urology, Teaching Hospital, Landesklinikum Korneuburg, Korneuburg, Austria
Male, Incontinence, Surgery, Retrospective Study
ePoster Station 4

12:40

#105 Effect of pelvic floor relaxing voiding position on uroflowmetry in men with lower urinary tract symptoms due to benign prostatic hyperplasia.

Presenter: Wit Viseshsindh

Viseshsindh W¹, Sarawong S¹, Sirisreetreerux P¹, Pummangura W¹
1. Ramathibodi hospital, Mahidol University
Benign Prostatic Hyperplasia (BPH), Pelvic Floor, Voiding Dysfunction
ePoster Station 4

12:45

#106 The long-term symptomatic outcome after transurethral resection of the prostate (TURP): Retrospective analysis depending on the urodynamic parameters before TURP

Presenter: Naoki Wada

Wada N¹, Hori J¹, Tamaki G¹, Kita M¹, Kakizaki H¹
1. Asahikawa Medical University
Benign Prostatic Hyperplasia (BPH), Bladder Outlet Obstruction , Retrospective Study, Male, Surgery
ePoster Station 4

12:05

#107 Relationship of nocturnal polyuria and combination anti-hypertensive drug therapy

Presenter: Matthew Epstein

Epstein M¹, Thomas M¹, Victor R², Weiss J P¹
1. SUNY Downstate Department of Urology, 2. Cedars-Sinai Smidt Heart Institute
Voiding Diary, Nocturia, Male
ePoster Station 5

12:10

#108 Cernitin pollen extract can improve overactive bladder condition in a rat model of non-bacterial prostatitis in short term.

Presenter: Yamanaka Naoyuki

Naoyuki Y¹, Kenichi M¹, Shinsuke M¹, Hiromitsu M¹
1. Oita University
Basic Science, Benign Prostatic Hyperplasia (BPH), Animal Study
ePoster Station 5

12:15

#109 Are poor response and adverse events predictable following Botulinum toxin-A injections for refractory idiopathic overactive bladder?

Presenter: Arun Sahai

Abrar M M¹, Stroman L¹, Solomon E¹, Roberts C¹, Taylor C¹, Malde S¹, Sahai A¹
1. Guy's and St Thomas' NHS Foundation Truat & King's College London
Detrusor Overactivity, Overactive Bladder, Voiding Dysfunction
ePoster Station 5

12:20

#110 Preoperative ultrasound-guided pelvic floor muscle training facilitates continence recovery in the early phase after robot assisted radical prostatectomy.

Presenter: Yasuhiko Igawa

Yoshida M¹, Matsunaga A², Fijimura T³, Sato Y³, Kamei J³, Watanabe D³, Aizawa N⁴, Shinoda Y⁵, Haga N⁵, Kume H³, Igawa Y⁴, Sanada H⁶
1. Department of Imaging Nursing Science, Graduate School of Medicine, The University of Tokyo, Japan, 2. Department of Rehabilitation Medicine, The University of Tokyo Hospital, Tokyo, Japan, 3. Department of Urology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan, 4. Department of Continence Medicine, The University of Tokyo Graduate School of Medicine, Tokyo, Japan, 5. Department of Rehabilitation Medicine, The University of Tokyo Graduate School of Medicine, Tokyo, Japan, 6. Department of Gerongtological Nursing, The University of Tokyo Graduate School of Medicine, Tokyo, Japan
Incontinence, Rehabilitation, Pelvic Floor, Male, Prospective Study
ePoster Station 5

12:25

#111 Vesomni improves quality of life in men with lower urinary tract symptoms in routine clinical practice in Europe

Presenter: Moses Huang

Foley S¹, Huang M², Rosa Arias J³, Skoumal R⁴, Walters C², Yavuz Y⁵, De Wachter S G⁶, Rees J⁷
1. Reading Urology Partnership, Berkshire, UK, 2. Astellas Pharma Europe Ltd., Chertsey, UK, 3. Hospital “Santiago Apóstol” Miranda de Ebro, Spain, 4. Urocentrum Brno, Czech Republic, 5. Astellas Pharma Global Development, Leiden, The Netherlands, 6. University Hospital Antwerpen, Edegem, Belgium, 7. Brockway Medical Centre, Nailsea, UK
Benign Prostatic Hyperplasia (BPH), Quality of Life (QoL), Overactive Bladder
ePoster Station 5

12:30

#112 Responder Analysis - A new method to document a clinically meaningful treatment benefit in nocturia

Presenter: Fredrik Andersson

Weiss J P¹, Malmberg A², Andersson F²
1. Department of Urology, SUNY Downstate College of Medicine, Brooklyn, New York, 2. Ferring Pharmaceuticals, Denmark
Outcomes Research Methods, Nocturia, Quality of Life (QoL), Urgency/Frequency
ePoster Station 5

12:35

#113 Why Do People Void At Night

Presenter: Paige De Rosa

Weiss J P¹, Blaivas J², De Rosa P³, Dayan L⁴, Smith M¹
1. SUNY Downstate, Dept. of Urology, 2. Icahn School of Medicine at Mount Sinai, Dept. of Urology, 3. SUNY Downstate College of Medicine, 4. Institute for Bladder and Prostate Research
Quality of Life (QoL), Voiding Diary, Nocturia, Voiding Dysfunction
ePoster Station 5

12:40

#114 Imidafenacin mediates nocturnal antidiuresis through concentration of urine osmolality

Presenter: Mamoru Hashimoto

Hashimoto M¹, Shimizu N¹, Ohzeki T¹, Minami T¹, Nozawa M¹, Yoshimura K¹, Uemura H¹, Tahara H², Hirayama A³
1. Kindai University Faculty of Medicine, 2. Mimihara General Hospital, 3. Nara Hospital Kindai University Faculty of Medicine
Nocturia, Overactive Bladder, Voiding Diary
ePoster Station 5

12:45

#115 Nocturia induced by the restraint stress is involved with alternation of circadian gene expression in the mouse bladder.

Presenter: Tatsuya Ihara

Ihara T¹, Mitsui T¹, Tuschiya S¹, Kanda M¹, Kira S¹, Nakagomi H¹, Sawada N¹, Yoshiyama M¹, Takeda M¹
1. Deparment of Urology, University of Yamanashi
Basic Science, Nocturia, Animal Study
ePoster Station 5

12:50

#116 Short-term retrospective analysis of voiding diary of patients with non-urological cancer referred to urologist for new-onset nocturia after surgery

Presenter: Sung Han Kim

Kim S H¹, Joung J Y¹, Ho Kyung Seo H K¹
1. Department of Urology, Center for Prostate Cancer, National Cancer Center, Goyang, Korea
Questionnaire, Quality of Life (QoL), Voiding Diary, Nocturia, Urodynamics Techniques
ePoster Station 5

12:55

#117 Effects and safeties of desmopressin on nocturia in elderly men

Presenter: Ke-ji Xie

Luo Z¹, Xie K¹
1. Department of Urology,Guangzhou First People’s Hospital,Guangzhou Medical University
Male, Nocturia, Voiding Diary, Quality of Life (QoL)
ePoster Station 5

12:05

#118 The impact of nocturia on patient reported sleep quality

Presenter: Carla Romano

Romano C¹, Lewis S¹, Barrett A¹, Andersson F²
1. RTI Health Solutions, 2. Ferring Pharmaceuticals
Outcomes Research Methods, Nocturia, Quality of Life (QoL)
ePoster Station 6

12:10

#119 Does successful treatment of urinary urgency improve comorbidities in patients with nocturia?

Presenter: Wendy F Bower

Chin K S¹, Rose G E¹, Ervin C F¹, Ong T J¹, Whishaw D M¹, Bower W F¹
1. The Royal Melbourne Hospital
Nocturia, Overactive Bladder, Urgency/Frequency
ePoster Station 6

12:15

#120 Chronic ischemia causes uroplakin defect in rat urinary bladder mucosa

Presenter: Hidenori Akaihata

Akaihata H¹, Onagi A¹, Ryo T¹, Ruriko H¹, Junya H¹, Masao K¹, Ogawa S¹, Haga N¹, Hosoi T², Ishibasi K¹, Aikawa K¹, Kojima Y¹
1. Department of Urology Fukushima medical university School of Medicine, 2. Takeda General Hospital
Animal Study, Overactive Bladder, Sensory Dysfunction
ePoster Station 6

12:20

#121 Urinary monocyte chemoattractant protein-1 (MCP-1) Expression, Quality of Life and Severity of symptoms in Patient with Overactive Bladder (OAB) in response to successful treatment

Presenter: Bilal Farhan

Farhan B¹, Ghoniem G¹, Zaldivar F¹
1. University of California, Irvine
Overactive Bladder, Quality of Life (QoL), Questionnaire
ePoster Station 6

12:25

#122 The management of overactive bladder in daily practice in Turkey: Turkish Continence Society multicentric study

Presenter: Ali Ersin Zümrütbas

Zümrütbas A E¹, Çitgez S², Acar Ö³, Izol V⁴, Uzun H⁵, Kabay S⁶, Sancak E B⁷, Yazici C⁸, Erdogan M S², Tarcan T³, Demirkesen O⁹
1. Pamukkale University, 2. Cerrahpasa School of Medicine, 3. Koç University, 4. Çukurova University, 5. Recep Tayyip Erdagan University, 6. Dumlupinar University, 7. Çanakkale Onsekiz Mart Üniversity, 8. Namik Kemal University, 9. Forte Urology
Overactive Bladder, Pharmacology, Urgency Urinary Incontinence
ePoster Station 6

12:30

#123 Urothelial MaxiK potassium channel regulates overall bladder metabolism: a factor in diabetic bladder disease.

Presenter: Kelvin Davies

Davies K¹, Wang Y¹
1. Albert Einstein College of Medicine
Basic Science, Biochemistry , Molecular Biology, Overactive Bladder, Physiology
ePoster Station 6

12:35

#124 Pelvic irradiation induces two bladder phenotypes which are dichotomized at the 10 percent voiding efficiency threshold – small capacity end stage overactive bladder and large capacity underactive bladder

Presenter: Amy D Dobberfuhl

Dobberfuhl A D¹, Briggs M A², Wen Y², Diaz E C¹, Graves E E³, Ning S³, Knox S J³, Chen B²
1. Stanford University, Dept. of Urology, 2. Stanford University, Dept. of Obstetrics and Gynecology, 3. Stanford University, Dept. of Radiation Oncology
Animal Study, Basic Science, Underactive Bladder, Overactive Bladder, Voiding Dysfunction
ePoster Station 6

12:40

#125 Does incorporation of an overactive bladder care pathway improve followup and progression to third line therapies?

Presenter: Anh Nguyen

Du C¹, Berg W², Wang Y¹, Kapadia K¹, Huang Z¹, Nguyen A¹, Cheung A¹, Weissbart S², Kim J²
1. Stony Brook School of Medicine, 2. Stony Brook University Department of Urology
Overactive Bladder, Urgency/Frequency, Voiding Dysfunction , Neuromodulation
ePoster Station 6

12:05

#126 Long-time change of symptoms severity and symptom-specific bother in treatment of female Overactive bladder (OAB) patients

Presenter: Atsuko Fujihara

Fujihara A¹, Fukui A¹, Saito Y¹, Ushijima S¹, Ukimura O¹
1. Kyoto prefectural university of medicine
Female, Overactive Bladder, Urgency Urinary Incontinence
ePoster Station 7

12:10

#127 Safety and tolerability of overactive bladder treatments using a large integrated database of mirabegron clinical studies involving >10,000 overactive bladder patients

Presenter: Christopher R Chapple

Chapple C R¹, Cruz F², Heesakkers J P F A³, Cardozo L⁴, Milsom I⁵, Wagg A⁶, Staskin D⁷, Herschorn S⁸, Stoelzel M⁹, Schermer C R¹⁰, Siddiqui E¹¹
1. Royal Hallamshire Hospital, 2. Hospital S João and Faculty of Medicine/i3S Institute, 3. Radboudumc, 4. King’s College Hospital, 5. Institute of Clinical Sciences, 6. University of Alberta, 7. St. Elizabeth's Medical Center, 8. University of Toronto, 9. Astellas Pharma Europe, 10. Astellas Pharma US, 11. Astellas Pharma
Overactive Bladder, Constipation, Clinical Trial, Stress Urinary Incontinence, Urgency Urinary Incontinence
ePoster Station 7

12:15

#128 NLRP3/Il-1β Mediates Changes in Urothelial Muscarinic Receptors M2 and M3 during Bladder Outlet Obstruction in Rats

Presenter: Francis Hughes

Hughes F¹, Jett A¹, Pines S¹, Tolbert S¹, Jin H¹, Purves T¹
1. Duke University Medical Center
Bladder Outlet Obstruction , Overactive Bladder, Physiology
ePoster Station 7

12:20

#129 The impact of ovary hormone deficiency on high fat and high sugar diet - induced overactive bladder in a rat model

Presenter: Cheng-Yu Long

Juan Y¹, Chuang S², Lu J³, Long C⁴, Lin K⁵, Wu W⁶, Lee Y⁷, Chen S⁷
1. Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan;, 2. Translational Research Center, Cancer Center, Department of Medical Research, Kaohsiung Medical University, Kaohsiung, Taiwan, 3. Graduate Institute of Medical Science, Kaohsiung Medical University, Kaohsiung, Taiwan, 4. Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, 5. Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;, 6. Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan., 7. Department of Urology, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan
Basic Science, Molecular Biology, Overactive Bladder
ePoster Station 7

12:25

#130 Gender difference in the association between obesity and urinary urgency. Findings from analysis of 2,568 healthy young and middle-aged adults.

Presenter: Hiroshi Kiuchi

Kiuchi H¹, Inagaki Y¹, Ueda N¹, Fukuhara S¹, Miyagawa Y¹, Takezawa K¹, Takao T¹, Tsujimura A¹, Nonomura N¹
1. Osaka University Graduate School of Medicine, Department of Urology, Suita, Japan
Urgency/Frequency, Overactive Bladder, Quality of Life (QoL)
ePoster Station 7

12:30

#131 OnabotulinumtoxinA Retreatment Not Associated With an Increased Risk of Clean Intermittent Catheterization in Patients With Idiopathic Overactive Bladder: Pooled Analysis of Randomized Controlled Trials

Presenter: Anand Patel

Rovner E¹, Cruz F², Sobol J³, McCammon K⁴, Hamid R⁵, Radomski S⁶, Orejudos A⁷, Patel A⁸, Lemack G⁹
1. Medical University of South Carolina, Charleston, SC, USA, 2. Hospital S. João & Universidade Do Porto, Porto, Portugal, 3. Michigan Institute of Urology, West Bloomfield, MI, 4. Eastern Virginia Medical School, Norfolk, VA, USA, 5. University College London Hospitals, London, UK, 6. University of Toronto, Toronto, ON, Canada, 7. Allergan plc, Irvine, CA, USA, 8. Allergan plc, Marlow, UK, 9. University of Texas Southwestern Medical Center, Dallas, TX, USA
Incontinence, Overactive Bladder, Urgency/Frequency
ePoster Station 7

12:35

#132 Validation of a 3-day electronic bladder diary as an app for smart-phone

Presenter: Luís López-Fando Lavalle

Mateu Arrom L¹, Peri L², López-Fando Lavalle L³, Franco A², Jiménez-Cidre M A³, Alcaraz A²
1. Fundació Puigvert, Barcelona, 2. Hospital Clínic, Barcelona, 3. Hospital Ramón y Cajal, Madrid
Questionnaire, Voiding Diary, Nocturia, Overactive Bladder, New Instrumentation
ePoster Station 7

12:40

#133 Water avoidance stress induced bladder overactivity in mice is associated with enhanced contractile bladder responses

Presenter: Eliza Grace West

West E G¹, Sellers D¹, Chess-Williams R¹, McDermott C¹
1. Bond University
Animal Study, Overactive Bladder, Voiding Dysfunction
ePoster Station 7

12:45

#134 Urinary ATP concentration is dependent on the time since the previous void and not dilution.

Presenter: Arun Sahai

McLatchie L¹, Dasgupta P¹, Fry C H², Sahai A¹
1. Guy's Hospital London, 2. University of Bristol
Basic Science, Overactive Bladder, Outcomes Research Methods, Female, Male
ePoster Station 7

12:50

#135 Prospective study to evaluate quality of life with percutaneous tibial neuromodulation in drug-naïve patients with overactive bladder syndrome

Presenter: Peter Sand

Kobashi K¹, Margolis E², Sand P³, Siegel S⁴, Khandwala S⁵, Newman D K⁶, Nitti V⁷, MacDiarmid S⁸, Michaud E⁹, Kan F⁹
1. Virginia Mason Medical Center, 2. Urologic Research and Consulting LLC, 3. NorthShore University Health-System, 4. Metro Urology, 5. Advanced Urogynecology of Michigan PC, 6. Division of Urology, University of Pennsylvania, 7. NYU School of Medicine, 8. Alliance Urology Specialists, 9. Medtronic
Overactive Bladder, Urgency Urinary Incontinence, Prospective Study, Clinical Trial, Quality of Life (QoL)
ePoster Station 7

12:55

#136 Can intravesical OnabotulinumtoxinA injections trigger cardiac arrhythmia?

Presenter: Pawel Miotla

Miotla P¹, Olejniczak P², Futyma K¹, Wrobel A¹, Tomaszewski M³, Bogusiewicz M¹, Wawrysiuk S¹, Rechberger T¹
1. 2nd Department of Gynaecology, Medical University of Lublin, Poland, 2. Department of Urology, SPZOZ Staszow, Poland, 3. Department of Cardiology, Medical University of Lublin, Poland
Overactive Bladder, Urgency Urinary Incontinence, Outcomes Research Methods, Pharmacology
ePoster Station 7

12:05

#137 “Incremental Syringe” a novel invention of a user friendly syringe to inject botulinum toxin with improved accuracy, precision, and speed

Presenter: Majid Mirzazadeh

Mirzazadeh M¹, Gillispey G², Russell K³, Brown P⁴
1. Wake Forest Medical School, 2. Virginia Tech – Wake Forest School of Biomedical Engineering Sciences, 3. Wake Forest Innovations, 4. Wake Forest University
Detrusor Overactivity, Other, Overactive Bladder
ePoster Station 8

12:10

#138 What’s normal? Should urinary creatinine or osmolarity be used to normalise urinary protein measurements?

Presenter: Kate H Moore

Ognenovska S¹, Cheng Y¹, Li A¹, Mansfield K J², Moore K H¹
1. Department of Urogynaecology, University of New South Wales at St. George Hospital, Kogarah NSW 2217, Australia, 2. School of Medicine, University of Wollongong, Wollongong NSW 2522, Australia
Basic Science, Overactive Bladder, Infection, other, Physiology
ePoster Station 8

12:15

#139 Urologist´s perspective about factors that affect treatment adherence in overactive bladder syndrome. Is it possible to change?

Presenter: Carlos Muller-Arteaga

Muller-Arteaga C¹, Adot-Zurbano J M², Esteban-Fuertes M³, Cozar-Olmo J M⁴
1. Complejo Hospitalario Universitario de Ourense. Spain, 2. Hospital Universitario de Burgos. Spain, 3. Hospital Nacional de Parapléjicos. Toledo. Spain, 4. Hospital Universitario Virgen de las Nieves. Granada. Spain
Overactive Bladder, Pharmacology, Questionnaire
ePoster Station 8

12:20

#140 Blebbistatin reveals beneficial effect on the cystometric parameters in the animal model of the detrusor overactivity

Presenter: Tomasz Rechberger

Wróbel A¹, Nowakowski L¹, Rechberger E¹, Banczerowska-Górska M², Gogacz M¹, Semczuk A¹, Poleszak E³, Dudka J⁴, Rechberger T¹
1. Second Department of Gynecology, Medical University of Lublin, Lublin, Poland, 2. Gynaecological and Obstetrics Hospital in Walbrzych, Walbrzych, Poland, 3. Chair and Department of Applied Pharmacy, Medical University of Lublin, Lublin, Poland, 4. Chair and Department of Toxicology, Medical University of Lublin, Lublin, Poland
Detrusor Overactivity, Overactive Bladder, Urodynamics Techniques, Animal Study, Pharmacology
ePoster Station 8

12:25

#141 Efficacy and Safety of tamsulosin and mirabegron combination treatment in women patients with detrusor overactivity and impaired contractility

Presenter: Seong Tae Cho

Oh C Y¹, Lee S H¹, Cho S T¹, Kim Y H², Lee G W², Bae J H³, Yoon H⁴, Shin D G⁵, Kim J H⁶
1. Hallym Universtiy College of Medicine, Sacred Heart Hospital, Anyang, Korea, 2. Soon Chun Hyang University, College of Medicine, Bucheon, Korea, 3. Korea University College of Medicine, Ansan, Korea, 4. Ewha University College of Medicine, Seoul, Korea, 5. Pusan National University College of Medicine, Pusan, Korea, 6. Yonsei University College of Medicine, Seoul, Korea
Overactive Bladder, Pharmacology, Underactive Bladder, Voiding Dysfunction
ePoster Station 8

12:30

#142 Safety, efficacy and persistence following daily mirabegron use for overactive bladder: 3-year results from a japanese post-marketing surveillance study

Presenter: Daisuke Kato

Kato D¹, Tabuchi H¹, Uno S²
1. Medical Science, Medical Affairs, Astellas Pharma Inc., Tokyo, Japan, 2. Japan-Asia Data Science, Development, Astellas Pharma Inc., Tokyo, Japan
Overactive Bladder, Prospective Study, Incontinence
ePoster Station 8

12:35

#143 Pilot study evaluating the effects of transcutaneous tibial nerve stimulation on urinary symptoms in female patients with multiple sclerosis reporting overactive bladder

Presenter: Cansu Polat

Polat C¹, Tulek Z¹, Kurtuncu M², Gunduz T², Panicker J N³, Eraksoy M²
1. Istanbul University Florence Nightingale Faculty of Nursing, Istanbul,Turkey, 2. Istanbul University Istanbul Faculty of Medicine Department of Neurology,Istanbul,Turkey, 3. University College London Hospitals National Hospital for Neurology and Neurosurgery Department of Uro-Neurology, London, United Kingdom
Neuromodulation, Female, Multiple Sclerosis, Overactive Bladder
ePoster Station 8

12:40

#144 A novel and original method to target the bladder trigone with transvaginal ultrasound injection under transabdominal cystoscopic guidance – technical proof of feasibility study in the cadaver

Presenter: Raveen Syan

Syan R¹, Olivas J C², Comiter C V¹, Srivastava S², Dobberfuhl A D¹
1. Stanford University, Dept. of Urology, 2. Stanford University, Dept. of Surgery
Anatomy, Overactive Bladder, New Instrumentation, Pre-Clinical testing, Basic Science
ePoster Station 8

12:45

#145 Predictors of Poor Response Parameters to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder

Presenter: Samer Shamout

Shamout S¹, Bouchard B¹, Kabbara H², Corcos J¹, Campeau L¹
1. Division of Urology, Department of Surgery, Jewish General Hospital, McGill University, Montreal, Quebec, Canada, 2. Statistical Research and Analysis Consultancy firm (Statrac), Montreal, Quebec, Canada
Overactive Bladder, Sensory Dysfunction, Retrospective Study
ePoster Station 8

12:50

#146 Trends in the Management of Overactive Bladder in the United States from 2003-2015

Presenter: Raveen Syan

Syan R¹, Zhang C¹, Enemchukwu E¹
1. Stanford University
Incontinence, Overactive Bladder, Urgency Urinary Incontinence, Urgency/Frequency, Neuromodulation
ePoster Station 8

12:55

#147 Benefit-Risk Evaluation of Tolterodine (4 mg) and Fesoterodine (Fixed and Flexible Dosing): Using Multi-criteria Decision Analysis Modelling to Help Physicians Optimise Treatment in Patients Diagnosed With Overactive Bladder

Presenter: Christopher R Chapple

Chapple C R¹, Phillips L², Pawinski R³, Mauer J³, Lizarraga I³, Chaudhuri S³
1. University of Sheffield, 2. London School of Economics, 3. Pfizer Inc
Overactive Bladder, Mathematical or statistical modelling, Retrospective Study
ePoster Station 8

12:05

#148 5 Years’ Experience of High Adherence Rate of Mirabegron and Its Combined Pharmacotherapies in Patients with Overactive Bladder in Japan

Presenter: Masayuki Takeda

Takeda M¹, Uchiyama H², Mitsui T¹, Hiraoka M¹, Matsuda Y¹, Sawada N¹, Kira S¹, Ihara T¹, Nakagomi H¹, Imai Y¹
1. Department of Urology, University of Yamanashi, 2. 2) Uchiyama Urological Clinic
Overactive Bladder, Retrospective Study, Male, Female
ePoster Station 9

12:10

#149 The incidence of de novo overactive bladder after Milligan Morgan hemorrhoidectomy

Presenter: Azimdjon Tursunkulov

Tursunkulov A¹, Alidjanov N², Muhamed-Aliev A², Ibragimov A², Rakhmatov A²
1. Republican Clinical Hospital #1 Ministry of Health Uzbekistan, 2. Republican Clinical Hospital#1 Ministry of Health
Female, Overactive Bladder, Surgery, Pain, Pelvic/Perineal
ePoster Station 9

12:15

#150 Succinate induces relaxation of murine bladders in-vivo and ex-vivo

Presenter: Abubakr H Mossa

Mossa A H¹, Velasquez Flores M¹, Cammisotto P¹, Campeau L¹
1. McGill University, Lady Davis Institute, Montreal, QC
Animal Study, Voiding Dysfunction , Pathophysiology
ePoster Station 9

12:20

#151 Symptom relief from OAB: what an"average" patient might expect: data from a pooled analysis of Fesoterodine treated patients

Presenter: Sender Herschorn

LaBossiere J R¹, Fernet M², Herschorn S¹, Carlsson M², Oelke M³, Wagg A⁴
1. University of Toronto, Toronto, Ont. Canada, 2. Pfizer Canada, Montreal, QC, Canada, 3. St. Antonius-Hospital Akademisches Lehrkrankenhaus der WWU Münster, Gronau, 4. University of Alberta, Edmonton, Alberta, Canada
Overactive Bladder, Incontinence, Pharmacology
ePoster Station 9

12:25

#152 How common are adverse events in patients with either a 50 or 100% resolution of OAB symptoms during treatment with fesoterodine?

Presenter: Adrian Wagg

Wagg A¹, LaBossiere J R², Oelke M³, Fernet M⁴, Carlsson M⁴, Herschorn S²
1. University of ALberta, Edmonton, Alberta, Canada, 2. University of Toronto, Toronto, Ont, Canada, 3. St. Antonius-Hospital Akademisches Lehrkrankenhaus der WWU Münster, Gronau, Germany, 4. Pfizer Canada, Montreal, QC, Canada
Overactive Bladder, Female, Male
ePoster Station 9

12:30

#153 Factors Affecting Children's DUI in Mainland China and Its Relationship with Disposable Diaper Use

Presenter: Jian Guo Wen

Wen J G¹, Xu P C², Wen Y B³, Wang X Z³, Wang Y H³, Li Z Z³, Shang X P³, Wang Q W³, Chen Y³, He Y L³, Jorgensen C⁴, Rittig S⁴
1. First Affiliated Hospital of Xinxiang Medical University, Pediatric Urodynamic Center of First Affiliated Hospital of Zhengzhou University, China., 2. Pediatric Urodynamic Center,First Affiliated Hospital of Zhengzhou University, Zhengzhou,China;International Joint Pediatric Urodynamic Laboratory Henan Province, China, 3. Pediatric Urodynamic Center,First Affiliated Hospital of Zhengzhou University, Zhengzhou,China, 4. Aarhus University Hospital
Questionnaire, Pediatrics, Voiding Dysfunction , Mixed Urinary Incontinence, Incontinence
ePoster Station 9

12:35

#154 A patient-reported, non-interventional, cross-sectional discrete choice experiment to determine treatment attribute preferences in treatment-naïve overactive bladder patients in the US

Presenter: Roger Dmochowski

Athavale A¹, Gooch K², Walker D², Suh M¹, Scaife J¹, Haber A¹, Hadker N¹, Dmochowski R³
1. Trinity Partners, LLC., Waltham, MA, 2. Medical Affairs, Americas, Astellas Pharmaceutical Global Development Inc., Northbrook, IL, 3. Urologic Surgery, Vanderbilt University, Nashville, TN
Incontinence, Urgency Urinary Incontinence, Overactive Bladder, Urgency/Frequency
ePoster Station 9

12:40

#155 Safety and efficacy of OnabotulinumtoxinA injections in octo and nonagenarians

Presenter: Howard B Goldman

Zahner P M¹, Giusto L L¹, Lloyd J C¹, Guzman-Negron J M¹, Agrawal S², Moore C K¹, Rackley R R¹, Vasavada S P¹, Goldman H B¹
1. Cleveland Clinic Foundation, 2. Case Western Reserve
Gerontology, Retrospective Study, Urgency/Frequency, Overactive Bladder, Urgency Urinary Incontinence
ePoster Station 9

12:45

#156 Safety and efficacy of OnabotulinumtoxinA injections in the setting of suprapubic catheters

Presenter: Howard B Goldman

Giusto L L¹, Zahner P M¹, Lloyd J C¹, Guzman-Negron J M¹, Agrawal S², Moore C K¹, Rackley R R¹, Vasavada S P¹, Goldman H B¹
1. Cleveland Clinic Foundation, 2. Case Western Reserve
Incontinence, Retrospective Study, Infection, Urinary Tract, Urgency Urinary Incontinence, Urgency/Frequency
ePoster Station 9

12:50

#157 Comparison of 6 months outcomes and side effects of sacral nerve stimulation and Botox-A injection in women with refractory overactive bladder：a systematic review and meta-analysis

Presenter: DeYi Luo

Zeng X¹, Sheng H¹, Luo D¹
1. west china hospital of SiChuan university
Female, Overactive Bladder, Pain, other
ePoster Station 9

12:05

#158 Effects of disposable diaper usage on defecation dysfunction in children aged 2 to 6 years: a retrospective epidemiological study

Presenter: Wei Zhou

Zhou W¹, Li S¹, Wen J G², Wang H¹, Chen J¹, Liu X¹, Jiang J¹, Li W¹, Sun F¹, Diao H¹, Yao F¹
1. Department of Urology,Shenzhen Children's Hospital,China, 2. Pediatric Urodynamic Center, Department of Urology ,The First Affiliated Hospital of Zhengzhou University,China
Bowel Evacuation Dysfunction, Pediatrics, Retrospective Study
ePoster Station 10

12:10

#159 Obesity and high-risk prostate cancer as risk factors for severe urinary incontinence after robot-assisted radical prostatectomy

Presenter: Ryo Tanji

Tanji R¹, Haga N¹, Onagi A¹, Honda R¹, Hoshi S¹, Hata J², Sato Y¹, Akaihata H², Kataoka M¹, Ogawa S¹, Ishibashi K¹, Kojima Y¹
1. Fukushima medical university, 2. Takeda general hospital
Surgery, Incontinence, Retrospective Study
ePoster Station 10

12:15

#160 Characteristics of 5-α-reductase-inhibitor-induced prostate volume reductions

Presenter: Lee Changho

Jong-hyun Y¹, Changho L², Seung Whan D³, Ki Hong K², Hee Jo Y², Doo Sang K², Yun Soo J²
1. Soonchunhyang University Gumi Hospital, 2. Soonchunhyang University Cheonan Hospital, 3. Soonchunhyang University Seoul Hospital
Anatomy, Benign Prostatic Hyperplasia (BPH), Pharmacology
ePoster Station 10

12:20

#161 Transient stress urinary incontinence (SUI) post Holmium Laser Enucleation of the Prostate (HoLEP)

Presenter: Jenny Guo

Guo J¹, Teplitsky S¹, Syed A¹, Shenot P J¹, Das A¹
1. Department of Urology, Sidney Kimmel Medical College at Thomas Jefferson University
Male, Stress Urinary Incontinence, Incontinence, Surgery
ePoster Station 10

12:25

#162 Influence of nerve-sparing procedure on lower urinary tract symptoms after robot-assisted radical prostatectomy

Presenter: Masashi Honda

Honda M¹, Tsounapi P¹, Kimura Y¹, Kawamoto B¹, Morizane S¹, Hikita K¹, Saito M², Takenaka A¹
1. Department of Urology, Tottori University Faculty of Medicine, 2. Department of Pharmacology, Kochi Medical School
Incontinence, Voiding Dysfunction , Questionnaire
ePoster Station 10

12:30

#163 Dorsal onlay buccal mucosa urethroplasty for female stricture: a single-center series

Presenter: Benoit Peyronnet

Peyronnet B¹, Sussman R¹, Malacarne D¹, Palmerola R¹, Granieri M¹, Zhao L¹, Rosenblum N¹, Nitti V¹, Brucker B M¹
1. NYU
Surgery, Retrospective Study, Female, Bladder Outlet Obstruction
ePoster Station 10

12:35

#164 Decreased sexual function after Sachse urethrotomy, regardless of the use of clean intermittent catherization

Presenter: Michael, R van Balken

Westgeest M¹, Goosen E E C¹, van Balken M R¹
1. Rijnstate Hospital
Sexual Dysfunction , Male, Questionnaire, Surgery
ePoster Station 10

12:40

#165 Management and Outcomes of Urethrovaginal Fistula Repair

Presenter: Rachel Barratt

Barratt R¹, Kotes S¹, Pakzad M H¹, Hamid R¹, Ockrim J L¹, Greenwell T J¹
1. University College London Hospital
Female, Surgery, Fistulas
ePoster Station 10

12:45

#166 Is there a role for surgical treatment in patients with Parkinson’s disease and benign prostatic obstruction?

Presenter: Benoit Peyronnet

Peyronnet B¹, Vurture G¹, Vanalderwerelt V², Tariel F³, Huet R³, Pradere B², Vincendeau S⁴, Bruyere F², Mathieu R³, Nitti V¹, Brucker B M¹
1. NYU, 2. University of Tours, 3. University of Rennes, 4. Univeristy of Rennes
Retrospective Study, Neuropathies: Central, Voiding Dysfunction , Surgery, Bladder Outlet Obstruction
ePoster Station 10

12:50

#167 Is there a role for concomitant pubovaginal sling at the time of midurethral sling excision for erosion or exposure?

Presenter: Benoit Peyronnet

Peyronnet B¹, Syan R¹, Enemchukwu E¹, Drain A¹, Mendhiratta N¹, Glass D¹, Sussman R¹, Palmerola R¹, Malacarne D¹, Rosenblum N¹, Nitti V¹, Brucker B M¹
1. NYU
Stress Urinary Incontinence, Grafts: Synthetic, Female, Surgery
ePoster Station 10

12:05

#168 The Structure and Management of a Urodynamic Database

Presenter: Andrew Gammie

Gammie A¹, Thomas L¹, Hashim H¹, Abrams P¹
1. Bristol Urological Institute
Questionnaire, Urodynamics Equipment, New Instrumentation
ePoster Station 11

12:10

#169 Dr. Why I am still not Dry {Urodynamic changes after successful VVF repair}.

Presenter: Aziz Abdullah

Abdullah A¹, Javed A¹, Memon I²
1. Liaquat National Hospital, 2. Liaquat University of Health Sciences Jamshore
Voiding Dysfunction , Stress Urinary Incontinence, Fistulas, Detrusor Overactivity, Pelvic Floor
ePoster Station 11

12:15

#170 Elderly patients with bladder outlet obstruction and associated neurological comorbidities: Can urodynamics be of help in selecting patients for surgery.

Presenter: Amr Abulseoud

Abulseoud A¹, Ali G¹
1. Alexandria University
Bladder Outlet Obstruction , Neuropathies: Central, Neuropathies: Peripheral, Surgery
ePoster Station 11

12:20

#171 Condom Catheter test revisited: A modified prototype for non-invasive measurement of isovolumetric bladder pressure.

Presenter: Mohamed Hassouna

Hassouna M¹, Shoukry M¹
1. Dept of Urology, Faculty of Medicine, Alexandria University
Urodynamics Techniques, New Instrumentation, Bladder Outlet Obstruction
ePoster Station 11

12:25

#172 Modified Condom catheter test for non-invasive measurement of isovolumetric bladder pressure in obstructed male patients: A pilot study.

Presenter: Mohamed Hassouna

Hassouna M¹, Shoukry M¹, Elmissiry M¹, Moussa A¹, Elkhawalka M¹
1. Dept of Urology, Faculty of Medicine, Alexandria University, Alexandria, Egypt
Urodynamics Techniques, New Instrumentation, Bladder Outlet Obstruction
ePoster Station 11

12:30

#173 The serotonin (5-HT)2A and 5-HT2C receptors are up-regulated in Onuf’s nucleus in rats with Diabetes Mellitus

Presenter: Baojun Gu

Cao N¹, Gu B¹
1. Department of Urology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
Pharmacology, Neuropathies: Central, Voiding Dysfunction
ePoster Station 11

12:35

#174 Valsalva´s maneuver in obstructed men do not improve Qmax as it was thought

Presenter: Christian Cobreros

Cobreros C¹, Del Villar M¹, Sarotto N¹, Garcia Penela E¹, Bechara A¹, Rey H¹
1. Hospital Carlos G Durand
Urodynamics Techniques, Prospective Study, Bladder Outlet Obstruction
ePoster Station 11

12:40

#175 A novel mobile uroflowmetry application for assessing low urinary tract symptoms

Presenter: Craig V Comiter

Comiter C V¹, Belotserkovsky E²
1. Stanford University, 2. BE Technologies
Urodynamics Equipment, Male, Benign Prostatic Hyperplasia (BPH)
ePoster Station 11

12:05

#176 Transfer of Kulkarni's one-stage double buccal mucosa urethroplasty technique from its origin to a tertiary care center

Presenter: Zafer Aybek

Zümrütbas A E¹, Özlülerden Y¹, Çelen S¹, Aybek Z¹
1. Pamukkale University School of Medicine, Department of Urology
Male, Surgery, Voiding Dysfunction
ePoster Station 12

12:10

#177 Relationship between ADRB3, ARHGEF10 and ROCK2 gene polymorphisms and clinical findings in over active bladder patients

Presenter: Zafer Aybek

Firat E¹, Aybek Z², Akgün S³, Küçüker K², Akça H³, Aybek H¹
1. Department of Medical Biochemistry, Medical Faculty of Pamukkale University, 2. Department of Urology, Medical Faculty of Pamukkale University, 3. Department of Medical Biology, Medical Faculty of Pamukkale University
Overactive Bladder, Pathophysiology, Biochemistry
ePoster Station 12

12:15

#178 The urodynamic findings in men and women with detrusor under activity

Presenter: Rizwan Hamid

Axell R G¹, Kocadag H¹, Trimboli M¹, Yasmin H¹, Duffy M¹, Pakzad M H¹, Hamid R¹, Ockrim J L¹, Greenwell T J¹
1. UCLH NHS Foundation Trust
Urodynamics Equipment, Underactive Bladder, Urodynamics Techniques, Detrusor Hypocontractility, Detrusor Overactivity
ePoster Station 12

12:20

#179 The Aetiology of Detrusor Underactivity

Presenter: Rizwan Hamid

Kocadag H¹, Trimboli M¹, Axell R G¹, Pakzad M H¹, Hamid R¹, Ockrim J L¹, Greenwell T J¹
1. UCLH NHS Foundation Trust
Urodynamics Equipment, Urodynamics Techniques, Underactive Bladder, Detrusor Hypocontractility
ePoster Station 12

12:25

#180 Comparison of real-time bladder sensation in non-invasive accelerated hydration and urodynamics in individuals without urinary urgency

Presenter: Adam Klausner

Nagle A S¹, Grochulski M², Naimi H A², Vinod N², Kolli H², Sheen D², Balthazar A², Speich J E¹, Klausner A²
1. Virginia Commonwealth University School of Engineering, 2. Virginia Commonwealth University School of Medicine
New Devices, Urodynamics Techniques, Prospective Study
ePoster Station 12

12:30

#181 Cystometry -ICS standard- sensation volumes are lower and pressures at sensation landmarks are higher in association with increasing urodynamic grade of bladder outflow obstruction during voiding, in men as well as in in women.

Presenter: Peter F W M Rosier

Rosier P F W M¹
1. University Medical Center Utrecht
Overactive Bladder, Physiology, Voiding Dysfunction , Bladder Outlet Obstruction
ePoster Station 12

12:35

#182 Impact of AUA urodynamics guidelines on practice patterns in the United States

Presenter: Elizabeth Rourke

Rourke E¹, Meeks W², Pichardo D², Kraus S¹
1. University of Texas at San Antonio; Department of Urology, 2. American Urological Association
Retrospective Study, Overactive Bladder, Stress Urinary Incontinence, Urgency Urinary Incontinence, Mixed Urinary Incontinence
ePoster Station 12

12:40

#183 Intubated flow in men must be compared to free flow to avoid overestimating the diagnosis of bladder outlet obstruction

Presenter: Francoise Valentini

Valentini F¹, Rosier P F W M², Zimmern P³, Nelson P¹
1. Hôpital Rothschild, Paris, France, 2. University Medical Center, Utrecht, The Nederlands, 3. UTSouthwestern Medical Center, Dallas, USA
Bladder Outlet Obstruction , Male, Mathematical or statistical modelling
ePoster Station 12

12:45

#184 Retrograde leak point pressure does not predict outcomes following male sling insertion

Presenter: Rizwan Hamid

Toia B¹, Jeth J¹, Ecclestone H¹, Pakzad M H¹, Hamid R¹, Greenwell T J¹, Ockrim J L¹
1. University College London Hospitals
Male, Stress Urinary Incontinence, Urodynamics Techniques, Incontinence
ePoster Station 12

12:50

#185 Clinical and urodynamic findings in women with detrusor overactivity

Presenter: Ana Laura Turner-Llaguno

Turner-Llaguno A L¹, Rodríguez-Colorado S¹, Ramírez-Isarraraz C¹, Granados-Martínez V¹, Gorbea-Chávez V¹
1. Instituto Nacional de Perinatología, Mexico City, Mexico
Detrusor Overactivity, Female, Retrospective Study, Urgency Urinary Incontinence, Urgency/Frequency
ePoster Station 12

Open Discussion ePosters

Scientific Open Discussion Session S7

Session Schedule

Comments

Chat